Correct Answer: D. Folate therapy caused rapid use of vitamin B12 stores aggravating symptoms
This patient presents with megaloblastic anemia with neurological manifestations (vibration sense loss = posterior column involvement). The critical clue is that neurological symptoms worsened after folate therapy despite hematologic improvement. This is the classic presentation of unmasked vitamin B12 deficiency.
Folate and B12 are interdependent in the one-carbon transfer cycle. When folate is repleted in a B12-deficient patient, folate becomes "trapped" in the methyltetrahydrofolate form because B12-dependent methionine synthase cannot regenerate tetrahydrofolate. This trapped folate is unavailable for DNA synthesis, yet the patient's bone marrow briefly improves due to residual B12 activity. However, the accelerated DNA synthesis from folate repletion rapidly depletes remaining B12 stores, which are critical for myelin synthesis. The result: hematologic improvement but neurological deterioration due to accelerated B12 depletion and progressive demyelination of posterior and lateral columns.
This is a well-documented phenomenon in Indian clinical practice, particularly in vegetarian populations with dietary B12 deficiency. The patient likely had combined deficiency (folate + B12) from the outset, but folate was given without B12 supplementation. The posterior column signs (vibration loss, gait disturbance) indicate subacute combined degeneration—irreversible if B12 is not repleted urgently. The correct management is simultaneous B12 and folate supplementation to prevent this complication.
Why the other options are wrong
A. Folate is not well absorbed — This is incorrect because the patient's anemia improved after folate therapy, proving folate was absorbed and utilized. Poor absorption would result in persistent anemia, not hematologic recovery followed by neurological worsening. This is a distractor that ignores the key clinical sequence. B. Folic acid therapy unmasked pyridoxine deficiency — Pyridoxine (B6) deficiency causes peripheral neuropathy and sideroblastic anemia, not megaloblastic anemia or posterior column signs. The patient's vibration sense loss and gait disturbance are classic for B12 deficiency (subacute combined degeneration), not B6 deficiency. This is a trap using 'unmasking' language to confuse with the correct mechanism. C. Deficiency of folate reductase in CNS — Folate reductase deficiency is an extremely rare genetic disorder causing CNS folate deficiency with seizures and developmental delay, not acquired megaloblastic anemia in a 30-year-old. This is a distractor using biochemical jargon to sound plausible but does not explain the clinical presentation or the temporal relationship between folate therapy and neurological worsening.
High-Yield Facts
- Folate repletion in B12 deficiency accelerates B12 depletion by increasing DNA synthesis demands, worsening neurological symptoms despite hematologic improvement.
- Subacute combined degeneration (posterior + lateral column demyelination) is the neurological hallmark of B12 deficiency and causes vibration/proprioception loss and gait ataxia.
- Combined B12 + folate deficiency is common in Indian vegetarian populations; always screen for B12 before or concurrent with folate therapy.
- Posterior column signs are irreversible if B12 repletion is delayed >6 months; early recognition and dual supplementation are critical.
- Methyltetrahydrofolate trap: B12 deficiency prevents conversion of methyltetrahydrofolate to tetrahydrofolate, making folate unavailable despite repletion.
Mnemonics
FOLATE TRAP in B12 deficiency Folate repletion → Overload of DNA synthesis → Loss of B12 stores → Accelerates neurological damage → Trapped methylfolate → Exacerbates symptoms. Use when a patient worsens neurologically after folate therapy alone. SCD = Subacute Combined Degeneration Sensory loss (vibration/proprioception first) → Column damage (posterior > lateral) → Demyelination (irreversible if delayed). Mnemonic for B12 deficiency neurological progression.
NBE Trap
NBE pairs "folate therapy" with "improvement" to lure students into thinking the treatment worked, then uses "worsening neurological symptoms" to test whether students understand the paradox of unmasked B12 deficiency. The trap is choosing option A (absorption) or B (pyridoxine) because they sound like "masking" mechanisms without recognizing the specific B12-folate metabolic interaction.
Clinical Pearl
In Indian clinical practice, vegetarian patients with megaloblastic anemia must be screened for serum B12 and methylmalonic acid levels before starting folate. A single case of folate-induced neurological deterioration can result in permanent disability. Always use B12 + folate together in combined deficiency; never give folate alone.
_Reference: Robbins & Cotran Pathologic Basis of Disease, Ch. 14 (Red Blood Cell Disorders); KD Tripathi Essentials of Medical Pharmacology, Ch. 50 (Vitamins); Harrison's Principles of Internal Medicine, Ch. 105 (Megaloblastic Anemias)_